Prevention of disease progression in a patient with a gastric cancer-re-recurrence. Outcome after intravenous treatment with the novel antineoplastic agent taurolidine. Report of a case

BACKGROUND: Taurolidine (TRD) is a novel agent with multimodal antineoplastic effects. We present the case of a tumor remission after intravenous administration of taurolidine in a patient with gastric cancer re-recurrence. CASE PRESENTATION: A 58 years old male patient suffering from a gastric aden...

Descripción completa

Detalles Bibliográficos
Autores principales: Braumann, Chris, Winkler, Goetz, Rogalla, Patrick, Menenakos, Charalambos, Jacobi, Christoph A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1544327/
https://www.ncbi.nlm.nih.gov/pubmed/16796759
http://dx.doi.org/10.1186/1477-7819-4-34

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1544327/
https://www.ncbi.nlm.nih.gov/pubmed/16796759
http://dx.doi.org/10.1186/1477-7819-4-34

Ejemplares similares